OssDsign - About the company
OssDsign is a public company based in Uppsala (Sweden), founded in 2011 by Thomas Engstrand, Hakan Engqvist, Bo Qwarnstrom and Jonas Aberg. It operates as a Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma. OssDsign has raised $19.7M in funding from investors like SEB, Eiffel Investment Group and Fouriertransform. The company has 85 active competitors, including 20 funded and 11 that have exited. Its top competitors include companies like ISTO Biologics, BONESUPPORT and Kuros Biosciences.
Company Details
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma. Its implants incorporate a proprietary calcium phosphate-based material composition, reinforced by titanium, and CAD-based manufacturing and design. It uses 3D printing technologies to produce implants using materials like titanium combined with cured ceramic tiles. Its products have applications in the reconstruction of facial bone after trauma, tumor resection or growth retardation due to irradiation, and the repair of hereditary facial defects such as paranasal augmentation in cleft patients and correction of hemifacial microsomia.
- Website
- www.ossdsign.com/
- Registered Address
- Uppsala, Uppsala county
Key Metrics
Founded Year
2011
Location
Uppsala, Sweden
Stage
Public
Total Funding
$19.7M in 6 rounds
Latest Funding Round
Ranked
4th among 85 active competitors
Employee Count
48 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with OssDsign
OssDsign is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Ossdsign Ab CIN: 0799.226.055 , Belgium, Active | Mar 06, 2023 | - | - | - |
Ossdsign Ab CIN: 556841-7546 , Sweden, Active | Dec 31, 2010 | - | - | - |
OssDsign's IPO details
OssDsign got listed on May 24, 2019.
Click here to take a look at OssDsign's IPO in detail
Sign up to download OssDsign's company profile
OssDsign's funding and investors
OssDsign has raised a total funding of $19.7M over 6 rounds. Its first funding round was on Jul 15, 2013. Its latest funding round was a Post IPO round on Jun 04, 2025 for $*****. 3 investors participated in its latest round. OssDsign has 12 institutional investors.
Here is the list of recent funding rounds of OssDsign:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 04, 2025 | 7472759 | Post IPO | 1223923 | 7996570 | 4411893 | 9902544 |
Sep 27, 2023 | 2577733 | Post IPO | 5386196 | 5345088 | 9105166 | |
Feb 12, 2019 | 9194718 | Series A | 3587306 | 7464497 | 8413754 |
View details of OssDsign's funding rounds and investors
OssDsign's founders and board of directors
Founder? Claim ProfileHere are the details of OssDsign's key team members:
- Thomas Engstrand: Co-Founder of OssDsign.
- Hakan Engqvist: Co-Founder of OssDsign.
- Bo Qwarnstrom: Co-Founder of OssDsign.
- Jonas Aberg: Co-Founder of OssDsign.
View details of OssDsign's Founder profiles and Board Members
OssDsign's employee count trend
OssDsign has 48 employees as of Aug 26. Here is OssDsign's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OssDsign's Competitors and alternates
Top competitors of OssDsign include ISTO Biologics, BONESUPPORT and Kuros Biosciences. Here is the list of Top 10 competitors of OssDsign, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ISTO Biologics 1997, St. Louis (United States), Acquired | Developer of treatments for cartilage and bone problems | $40.7M | 63/100 | |
2nd | BONESUPPORT 2000, Lund (Sweden), Public | Injectable, synthetic bone substitutes for remodeling | $101M | 61/100 | |
3rd | Kuros Biosciences 2000, Schlieren (Switzerland), Public | Provider of smart solutions for bone disease management | $24.6M | 60/100 | |
4th | Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma | $19.7M | 59/100 | ||
5th | OSSTEC 2021, London (United Kingdom), Series A | Developer of regenerative orthopedic implants | $4.68M | 56/100 | |
6th | Nanochon 2016, Burke (United States), Seed | Developer of 3D-printed implants for treating joint injuries | $11.3M | 55/100 | |
7th | K2M 2004, Leesburg (United States), Acquired | Spine solutions: implants, instruments, biologics, and enabling technologies | $21.5M | 52/100 | |
8th | Locate Bio 2001, Nottingham (United Kingdom), Series A | Developer next generation of orthobiologics products for the treatment of injuries | $31.6M | 44/100 | |
9th | ConforMIS 2004, Billerica (United States), Acquired | Developer of 3D-printed orthopedic products | $447M | 44/100 | |
10th | Tetrous 2019, Sherman Oaks (United States), Series A | Manufacturer of demineralized bone fiber implants for surgical enthesis repair | $8.69M | - | 42/100 |
Looking for more details on OssDsign's competitors? Click here to see the top ones
OssDsign's Investments and acquisitions
OssDsign has acquired SIRAKOSS. OssDsign has not made any investments as of now.Reports related to OssDsign
Here is the latest report on OssDsign's sector:
News related to OssDsign
Media has covered OssDsign for a total of 6 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
OssDsign Appoints Adam McCollister as Vice President of Sales to Accelerate U.S. Growth of Catalyst PlatformCision•Jun 25, 2026•OssDsign
•
OssDsign Catalyst® Bone Graft Shows Superior Performance in Trauma StudyCision•Jun 03, 2026•OssDsign
•
•
OssDsign Appoints Mark Waugh as CEO, Effective January 1, 2026Cision•Dec 10, 2025•OssDsign, Medacta International
•
OssDsign strengthens its commercial footprint in the Western U.S. through new agreement with IDNCision•Dec 05, 2025•OssDsign
•
•
•
OssDsign's Incentive Warrant Program 2022/2025 Begins, Potentially Boosting Cash by SEK 10 MillionCision•Jul 01, 2025•OssDsign
•
OssDsign shows 88.4% fusion rate in complex patient cohort from spinal fusion registry PROPELCision•Jun 26, 2025•OssDsign
•
OssDsign Completes SEK 158 Million Directed Share IssueGlobal Legal Chronicle•Jun 09, 2025•OssDsign, Setterwalls
Are you a Founder ?
FAQs about OssDsign
Explore our recently published companies
- BIA Home Care Service - Pittsburgh based, 2021 founded, Unfunded company
- JK Auto & Truck Repair - Marlton based, Unfunded company
- Lippert - Elkhart based, 1956 founded, Unfunded company
- AMZ Tech Solutions - Cedar Rapids based, Unfunded company
- ItsGuru - Houston based, 2006 founded, Unfunded company
- Anh Totti Nguyen - Unfunded company
